AI Chat
Loading data for SYK — first visit, this takes a few seconds.

Stryker Corporation

SYK · NYSE · USD

281.87 +6.31 (2.29%)

At close: Sep 14, 2026, 3:59 PM

Market Cap
$108.1B
Volume
2.93M
Next earnings date
Oct 29, 2026

Stryker Corporation (SYK) Stock Price, Analysis & Data

Intrinsic Value

Loading intrinsic value…

Analyst Forecast

Stock Forecasts →

Analyst forecast unavailable

12-month target · n/a analysts

Analyst Consensus: n/a

Interval:1D
Loading candles and signals…

Financial Performance

View financials →

Loading...

Latest Earnings

ReportedVs estimateYoY Change
Revenue$6.59Bn/a+9.42%
EPS$3,69+$0,20+17.89%

Next Earnings

after market closes.

Estimate · Upgrade →

View earnings details →

Metrics

Bid
281.97
Net Income (ttm)
3.73B
0.77
9.64
29.24
16.84
P/B (ttm)
4.51
P/S (ttm)
4.18
Earnings Date
Oct 29, 2026
Ask
285
Volume
2,930,766
Avg. Volume (20D)
2,613,024
Open
282.31
Previous Close
275.56
Day's Range
280.67 - 287.17
52-Week Range
267.00 - 392.55
Dividends
$3.52 (1.25%)
Ex-Dividend Date
Sep 30, 2026

About Stryker Corporation

View profile →
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan. Medical Devices · Healthcare

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Sector Healthcare
IPO Date Mar 17, 1980
Employees 56,000
Stock Exchange NYSE
Ticker Symbol SYK